Calyxt Announces Collaboration with NRGene® to Advance its Product Pipeline
November 11 2020 - 8:31AM
Business Wire
NRGene’s Genomics Platform to Accelerate
Calyxt’s Trait Discovery in Hemp
Calyxt, Inc. (NASDAQ: CLXT), a plant-based technology company,
today announced a research collaboration with NRGene® that includes
the adoption of NRGene’s cloud-based genomics platform to support
key Calyxt’s research projects. The genomics solutions are expected
to allow for more comprehensive evaluations to accelerate trait
discovery and breeding across multiple crops.
Calyxt is leveraging its proprietary breeding techniques and
TALEN® technology to optimize product performance and transition
hemp to a broad acre crop for use across food, industrial fiber and
therapeutic applications.
NRGene’s QuickGENETICS™ technology analyzes breeding
populations, delivers high resolution genetic mapping, and
generates unique genetic markers for high value traits. NRGene’s
CannaGene™ technology is an optimized and customizable genomics
database allowing for the search and discovery of novel gene
candidates to enable Calyxt targeting of key traits of interest in
hemp.
Calyxt is integrating NRGene’s genomic resources to build out
its proprietary predictive data analytics, which combines insights,
scientific data, predictive algorithms, and data visualization
tools to develop customized products to meet specific customer
requirements. The company is also adopting advanced technologies
like artificial intelligence, machine learning and augmented
reality to enhance its data analytics capabilities.
“The synergistic potential of combining NRGene’s genomic
resources with our evolving predictive analytics program will give
us a deeper understanding of the complex genomics of hemp and
discover novel pathways to target,” said Travis Frey, chief
technology officer at Calyxt. “Having access to NRGene’s technology
helps jumpstart our ability to quickly identify gene targets of
interest to optimize the hemp crop.”
“We are honored that Calyxt chose our technology solutions to
speed up their trait discovery and integration in hemp,” said Dr.
Gil Ronen, NRGene’s CEO and co-founder. “Hemp genome is still
relatively unresearched territory and Calyxt is in a great position
to lead the industry and develop new, disruptive varieties of hemp
for diverse key commercial markets.”
About Calyxt
Calyxt (NASDAQ: CLXT), based in Roseville, Minnesota, is a
technology company with a mission to deliver plant-based
innovations for a better world. Founded in 2010, Calyxt uses its
proprietary TALEN® gene editing technology to work with world-class
partners via technology licensing, product development, and seed
sale arrangements to revolutionize the way the world uses plants to
solve problems. For further information, please visit our website
at www.calyxt.com.
About NRGene
NRGene is a genomics company that provides turn-key solutions.
Relying on a vast proprietary database and AI-based technologies,
we provide the largest seed and food companies in the world with
the computational tools they need to maximize their crop yield,
significantly saving them time and cost. NRGene’s tools have
already been implemented by some of the leading agribiotech
companies worldwide, as well as the most influential research teams
in academia.
For more information please visit our website at
www.nrgene.com.
Forward-Looking Statements
This communication contains “forward-looking statements” within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. In some cases, you can
identify these statements by forward-looking words such as
“anticipates,” “believes,” “continue,” “estimates,” “expects,”
“targets,” “intends,” “may,” “might,” “plans,” “potential,”
“predicts,” “projects,” “should,” or “will,” the negative of these
terms and other similar terminology. Forward-looking statements in
this press release include statements about the potential impact of
the COVID-19 pandemic on our business and operating results; our
future financial performance; product pipeline and development; our
business model and strategies for commercialization and sales of
commercial products; regulatory progression; potential
collaborations, partnerships and licensing arrangements and their
contribution to our financial results, cash usage, and growth
strategies; and anticipated trends in our business. These and other
forward-looking statements are predictions and projections about
future events and trends based on our current expectations,
objectives and intentions and premised on current assumptions. Our
actual results, level of activity, performance, or achievements
could be materially different than those expressed, implied, or
anticipated by forward-looking statements due to a variety of
factors, including, but not limited to: the severity and duration
of the evolving COVID-19 pandemic and the resulting impact on
macro-economic conditions; the impact of increased competition,
including with respect to enhanced quality alfalfa; disruptions at
our or our collaborators’ key facilities; changes in customer
preferences and market acceptance of our or our partners’ products,
including hemp product candidates; competition for collaboration
partners and licensees and the successful execution of
collaborations and licensing agreements; the impact of adverse
events during development, including unsuccessful field trials or
development trials or disruptions in seed production; the impact of
improper handling of our product candidates by unaffiliated third
parties during development, such as the improper aerial spraying of
our high fiber wheat product candidate; failures by third-party
contractors; inaccurate demand forecasting, including with respect
to sales projections used by Calyxt management in determining
potential license revenues; the effectiveness of commercialization
efforts by commercial partners or licensees; our ability to make
grain sales on terms acceptable to us; the timing of our grain
sales; our ability to collect accounts receivable; disruptions to
supply chains, including transportation and storage functions;
commodity price conditions; the impact of changes or increases in
oversight and regulation; disputes or challenges regarding
intellectual property; proliferation and continuous evolution of
new technologies; management changes; dislocations in the capital
markets; and other important factors discussed under the caption
entitled “Risk Factors” in our Annual Report on Form 10-K and
subsequent filings on Form 10-Q or 8-K with the U.S. Securities and
Exchange Commission. Any forward-looking statements made by us are
based only on information currently available to us when, and
speaks only as of the date, such statement is made. Except as
otherwise required by securities and other applicable laws we do
not assume any obligation to publicly provide revisions or updates
to any forward-looking statements, whether as a result of new
information, future developments or otherwise, should circumstances
change.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201111005205/en/
Calyxt Media Contact: Trina Lundblad, Director of
Corporate Communications (612) 790-0514 media@calyxt.com
Calyxt Investor Relations Contact: Chris Tyson, Managing
Director MZ Group – MZ North America (949) 491-8235 CLXT@mzgroup.us
www.mzgroup.us
NRGene Media Contact: Yana Voldman, Marketing Director
(972)50-900-2844 yana.voldman@nrgene.com
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Calyxt (NASDAQ:CLXT)
Historical Stock Chart
From Sep 2023 to Sep 2024